MAX Chat
Company Analysis Organon & Co.
1. Summary
Advantages
- Price (10.04 $) is less than fair price (17.71 $)
- Dividends (7.58%) are higher than the sector average (1.28%).
- The company's current efficiency (ROE=429.85%) is higher than the sector average (ROE=-83.32%)
Disadvantages
- The stock's return over the last year (-56.43%) is lower than the sector average (-39.36%).
- Current debt level 67.78% has increased over 5 years from 0.986%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Organon & Co. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 5% | 0% | 2.1% |
| 90 days | -20.6% | -47.7% | 9.1% |
| 1 year | -56.4% | -39.4% | 18.8% |
OGN vs Sector: Organon & Co. has significantly underperformed the "Healthcare" sector by -17.07% over the past year.
OGN vs Market: Organon & Co. has significantly underperformed the market by -75.23% over the past year.
Stable price: OGN is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: OGN with weekly volatility of -1.09% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (10.04 $) is lower than the fair price (17.71 $).
Price significantly below the fair price: The current price (10.04 $) is 76.4% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (4.48) is lower than that of the sector as a whole (52.65).
P/E vs Market: The company's P/E (4.48) is lower than that of the market as a whole (61.82).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (8.19) is lower than that of the sector as a whole (10.87).
P/BV vs Market: The company's P/BV (8.19) is lower than that of the market as a whole (20.58).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.6039) is lower than that of the sector as a whole (4.03).
P/S vs Market: The company's P/S indicator (0.6039) is lower than that of the market as a whole (15.96).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (7.48) is lower than that of the sector as a whole (16.1).
EV/Ebitda vs Market: The company's EV/Ebitda (7.48) is lower than that of the market as a whole (19.26).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -12% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-12%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-8.87%).
5.4. ROE
ROE vs Sector: The company's ROE (429.85%) is higher than that of the sector as a whole (-83.32%).
ROE vs Market: The company's ROE (429.85%) is higher than that of the market as a whole (42.62%).
5.5. ROA
ROA vs Sector: The company's ROA (6.87%) is higher than that of the sector as a whole (6.38%).
ROA vs Market: The company's ROA (6.87%) is lower than that of the market as a whole (23.26%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (13.88%) is lower than that of the sector as a whole (15.06%).
ROIC vs Market: The company's ROIC (13.88%) is higher than that of the market as a whole (9.1%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 7.58% is higher than the average for the sector '1.28%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 7.58% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 7.58% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (34.38%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
